OK Biotech Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 435.89 million compared to TWD 300.51 million a year ago. Net income was TWD 53.77 million compared to net loss of TWD 0.166 million a year ago. Basic earnings per share from continuing operations was TWD 0.57. Diluted earnings per share from continuing operations was TWD 0.52. Basic earnings per share was TWD 0.57. Diluted earnings per share was TWD 0.52.
For the six months, sales was TWD 853.02 million compared to TWD 596.46 million a year ago. Net income was TWD 102.47 million compared to TWD 29.6 million a year ago. Basic earnings per share from continuing operations was TWD 1.09 compared to TWD 0.31 a year ago. Diluted earnings per share from continuing operations was TWD 0.96 compared to TWD 0.27 a year ago. Basic earnings per share was TWD 1.09 compared to TWD 0.31 a year ago. Diluted earnings per share was TWD 0.96 compared to TWD 0.27 a year ago.